🇺🇸 FDA

Company profile · Sponsor

Structure

Structure Therapeutics

GPCR · NYSE pharma SOUTH SAN FRANCISCO, CA, USA
Pipeline
13
Drugs
0
Patents
8

Quick answer

Structure (GPCR) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 13 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker GPCR
Exchange NYSE
Company type pharma
Headquarters SOUTH SAN FRANCISCO, CA, USA
SEC CIK 0001888886

Pipeline (13)

Search pipeline →

  1. Aleniglipron

    Structure

    Obese

    phase 2 small molecule active

    1 trial

  2. Aleniglipron or Placebo

    Structure

    Obesity, Overweight, or Chronic Weight Management

    phase 2 small molecule active

    2 trials

  3. GPC-100

    Structure

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  4. GSBR-1290

    Structure

    Overweight or Obesity

    phase 2 small molecule completed

    1 trial

  5. TG-0054

    Structure

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  6. TG-0054 (2.24 mg/kg)

    Structure

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  7. TG-0054 combined with G-CSF

    Structure

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  8. aleniglipron or placebo

    Structure

    Obesity

    phase 2 small molecule completed

    1 trial

  9. A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] GSBR-1290, in healthy participants

    Structure

    Not applicable - Healthy volonteers

    phase 1 other active

    1 trial

  10. GSBR-1290

    Structure

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. GSBR-1290 (Capsule/Tablet)

    Structure

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  12. TG-0054

    Structure

    Healthy

    phase 1 small molecule completed

    1 trial

  13. carotid-femoral pulse-wave velocity

    Structure

    Covid19

    other active

    1 trial

Patents (8)

Search patents →

  1. US 12279630

    Treatment and prevention of seed allergies

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12251417

    Antimicrobial compounds from the genus Delftia

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12139522

    T-cells comprising two different chimeric antigen receptors and uses thereof

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12134650

    Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer

    Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12084350

    Allotrope of carbon having increased electron delocalization

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12023348

    EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11944644

    T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11932871

    Methods of culturing t cells and uses of same

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Structure?

Structure (GPCR) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 13 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Structure sponsor?

We track 13 ClinicalTrials.gov-linked programs for Structure, including Aleniglipron and 12 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Structure company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.